Cigarette smoking has been linked to somatic genetic and epigenetic aberrations, including CpG island methylator phenotype (CIMP)-high, microsatellite instability (MSI)-high and BRAF mutation. These molecular features have been associated with synchronous primary colorectal cancers (CRCs). Thus, we examined the hypothesis that smoking might be associated with the risk of synchronous CRCs.
INTRODUCTION
Although colorectal cancers (CRCs) across a population demonstrate considerable genetic and epigenetic heterogeneity, the "fi eld eff ect" theory posits that neoplasms that develop in a background of common etiologic (genetic, lifestyle, or environmental) factors within a single individual may share molecular features ( 1, 2 ) . Cigarette smoking, an established CRC risk factor ( 3, 4 ) , serves as a possible exposure which may contribute to fi eld cancerization. Although the precise carcinogenic mechanism of cigarette smoking in CRC is unclear, cigarette smoking appears to associate most consistently with specifi c somatic alterations in CRC, including aberrant promoter methylation pattern (termed high-level CpG island methylator phenotype (CIMP-high)) ( 5-7 ), microsatellite instability (MSI) ( 5, (7) (8) (9) (10) (11) , and BRAF mutation (5) (6) (7) 12 ) . Importantly, experimental evidence suggests that cigarette smoking can directly drive the epigenomic instability associated with these molecular alterations through the induction of hypermethylation at CpG islands (13) (14) (15) .
Synchronous CRCs, which indicates the presence of two or more primary carcinomas separated by normal mucosa and identifi ed within a single individual at the time of cancer diagnosis (16) (17) (18) , are perhaps the most convincing clinical manifestation of a putative fi eld eff ect. Importantly, previous studies have demonstrated that somatic epigenetic signatures across synchronous CRCs are highly concordant ( 1, 19 ) . Furthermore, synchronous CRCs are associated with CIMP-high, MSI-high, and BRAF mutation, molecular markers that, as previously discussed, are also associated with smoking-induced carcinogenesis (19) (20) (21) (22) (23) (24) . Th erefore, we hypothesized that cigarette smoking might contribute directly to a fi eld eff ect that promotes multifocal cancer development. However, to our knowledge, no previous studies have prospectively examined the association of smoking with incidence of CRC according to tumor synchronicity status.
In this study, we tested this hypothesis by examining the relationship between cigarette smoking and incidence of CRCs according to tumor synchronicity status, utilizing the databases of two wellcharacterized, large, prospective cohorts: the Nurses' Health Study I (NHS) and the Health Professionals Follow-up Study (HPFS) .
METHODS

Study population
Th e NHS is a prospective U.S. cohort of 121,701 female registered nurses, who were 30-55 years of age at enrollment in 1976. Th e HPFS is a prospective cohort of 51,529 US male professionals, who were 40-75 years of age at enrollment in 1986. In both studies, biennial questionnaires have been mailed to participants to update information on lifestyle factors including smoking status, as well as diagnoses of diseases, including CRC. Participants have also provided self-reported average food intake using previously described and validated food frequency questionnaires ( 25, 26 ) . Th is study was approved by the Harvard T.H. Chan School of Public Health and Brigham and Women's Hospital Institutional Review Boards. Completion and return of the questionnaire was considered to imply informed consent. In the present study, we excluded men and women with a baseline history of cancer (except non-melanoma skin cancer), and those who did not provide dietary or smoking information on the baseline questionnaire ( see Supplementary Figure S1 online ). A total of 45,691 men and 88,614 women were eligible for inclusion in the analysis.
Assessment of smoking status
Collection of data on smoking habits within the two cohorts has been detailed previously ( 27 ) . In brief, current smoking status and the number of cigarettes smoked per day were reported by participants in biennial questionnaires, beginning in 1980 for NHS and 1986 for HPFS. At baseline, participants provided information on their age when they started smoking, age when they stopped (for former smokers), and the number cigarettes/day they smoked in the past. Based on this information, we calculated the duration of smoking cessation, cumulative pack-years smoked ((cumulative average of packs per day) multiplied by (number of years during which smoking occurred)), and the number of pack-years smoked before age 30.
Assessment of incident CRC and tumor synchronicity status
Identifi cation of incident CRC within the prospective cohorts has been detailed previously ( 27 ) . On each biennial questionnaire, participants were asked whether they had received a new or past diagnosis of colon or rectal cancer. Once a participant reported a diagnosis of CRC they were contacted to obtain consent to obtain and review medical records. For non-responders, we used the National Death Index and next-of-kin to identify diagnosis of CRC that contributed to death or that were a secondary diagnosis and then contacted next of kin to obtain permission to review medical records. At the time of this analysis, CRC incidence data were available up to 31 January 2010 for men (HPFS) and 1 June 2012 for women (NHS). All reported cases were confi rmed through medical record review. When available, formalin-fi xed paraffi n-embedded CRC tissue blocks were retrieved from hospitals where surgical resections of the cancer had occurred. Th e criteria defi ning synchronous CRCs have been described previously; all cases were reviewed by two study physicians (including S.O.), both of whom agreed on the synchronicity of each case ( 1 ). Synchronous CRC cases were strictly defi ned as the presence of two or more colorectal carcinomas with at least submucosal invasion (that is, stage pT1) that were clearly separated by normal intestinal mucosa at the fi rst diagnosis of cancer according to pathology reports or available tissue specimens. Any potential metastases mimicking synchronous tumors were excluded.
Assessment of tumor molecular characteristics
Detailed methods for the assessment of tumor molecular characteristics have been detailed previously ( 27 ) . Briefl y, DNA was extracted from formalin-fi xed paraffi n-embedded tumor and normal colon specimens. We conducted pyrosequencing of the BRAF (codon 600) oncogene ( 28 ) , MSI analysis ( 29 ) , and methylation analysis for 8 CIMP-specifi c CpG islands ( 30 ) using a validated bisulfi te DNA treatment and real-time polymerase chain reaction (MethyLight assay) ( 31 ) . Tissue for molecular analyses was available from at least one of the synchronous tumors in the majority of cases. Our previous studies have demonstrated signifi cant correlation between available synchronous tumor pairs' epigenetic profi les ( 1, 19 ) . Th erefore, we classifi ed individuals with synchronous CRC according to the molecular characteristics of the larger tumor among synchronous CRCs.
Statistical analysis
All statistical analyses were performed using SAS version 9.3 (SAS Institute, Inc., Cary, North Carolina). All statistical tests were twosided. Our primary hypothesis test was for heterogeneity between 'the association of smoking with synchronous CRC' and 'the association of smoking with solitary CRC' . To account for multiple hypothesis testing for each of the primary hypotheses associated with the fi ve smoking exposure variables (smoking status (never, former, current), cumulative pack-years smoked, pack-years smoked before age 30, age at initiation of smoking habit, and years of cessation (if applicable)), we corrected the standard two-sided signifi cance value to α =0.05/5=0.01 by Bonferroni correction. All other assessments, including evaluation of individual hazard ratio (HR) estimates, were secondary analyses.
To compare diff erential associations of smoking exposures with CRC risk by tumor synchronicity status, we conducted initial duplication-method Cox proportional hazards models and assessed for heterogeneity among the combined cohort ( 32 ) . Th is allows for the estimation of separate regression coeffi cients for smoking status stratifi ed by multiple outcomes (e.g., synchronous vs. solitary). Th e Anderson-Gill data structure were used to handle left truncation and time-varying covariates in an effi cient manner ( 33 ) . To control for confounding by age as fi nely as possible, we stratifi ed our analysis jointly by age at start of follow-up, calendar year of a given questionnaire cycle and sex. No violation of the proportionality of hazards assumption was observed for any of the smoking-related variables. For the primary hypothesis test, a likelihood ratio test was used to assess whether smoking exposures conferred diff erential risk for solitary vs. synchronous tumors. Tests for linear trend were performed using the ordinal categorical values (i.e., status) or the median value for continuous variable categories (i.e., pack-years). In addition to sex and age-adjusted models, we utilized multivariable-adjusted models including multiple potential confounders. All covariates used the most up-to-date questionnaire data collected before each follow-up cycle. Followup ended at diagnosis of CRC, death from other causes, or 31 Jan 2010 for men and 1 June 2012 for women, whichever occurred fi rst. Multivariable models were stratifi ed for time of questionnaire return, sex and age. Models were further adjusted for body mass index (<25 vs. 25-30 vs. ≥30 kg/m 2 ) before diagnosis, family history of CRC in any fi rst-degree relative, regular use of aspirin (≥2 tablets (325 mg) per week), physical activity level (quintiles of mean metabolic equivalent task score per week), red meat intake (quintiles of servings per day), total caloric intake (quintiles), alcohol consumption (0 or quartile of grams (g) per day), folate intake (quintiles of μ g per day), calcium intake (quintiles of mg per day), current multivitamin use, and postmenopausal hormone use (women only). Consistent with prior analyses ( 27 ) , the cumulative average of body mass index, physical activity, and red meat, caloric, alcohol, folate, and calcium intake was used to reduce within-individual variability and better represent long-term exposure. Before pooling the cohorts, we performed tests of heterogeneity using the Q statistic. Incidence rates of CRC for participants in a specifi c category of smoking status were calculated by dividing the number of incident cases by the number of person-years of follow-up. Th e age-adjusted incidence rate ratio (IRR) was calculated by dividing the incidence rate in one category by the incidence rate in the reference category and further stratifying by age. Age-standardized incidence rates were calculated based on the IRRs.
RESULTS
Th e age-adjusted baseline characteristics of the NHS and HPFS cohorts are shown in Table 1 . Using up to 32 years of follow-up of 88,614 women and 45,691 men with available smoking history data (encompassing 3,463,102 person-years), we documented 3,203 cases of incident CRC. Overall, compared with never smokers (incidence rate: 81 cases/100,000 person-years), the multivariable HRs for incident CRC were 1.17 (95% confi dence intervals (CI) 1.08-1.26; age-standardized incidence rate: 100 cases/100,000 person-years; IRR=1.23; 95% CI, 1.14-1.32) for former smokers and 1.09 (95% CI, 0.96-1.23; age-standardized incidence rate: 101 cases/100,000 person-years; IRR=1.25; 95% CI 1.11-1.41) for current smokers ( P trend =0.005; see Supplementary Table S1 online ). In addition, compared with never smokers, the risk of CRC increased according to cumulative pack-years smoked (≥40 packyears, multivariable HR=1.26; 95% CI, 1.14-1.39; P trend <0.0001), and pack-years smoked before age 30 (≥10 pack-years, multivariable HR=1.15; 95% CI, 1.04-1.26; P trend =0.005) confi rming that smoking is a modest risk factor for CRC overall ( see Supplementary Table S1 online ). Among these CRC cases, we were able to assess synchronicity status of 2,026 cases. From these 2,026 cases, we identifi ed 45 individuals with synchronous CRCs. No substantial heterogeneity was observed between the associations of smoking status with risk of CRC according to tumor synchronicity status by sex ( P heterogeneity ≥0.05; see Supple mentary Tables S2-S4 online which show cohort specifi c results for smoking exposures and incident CRC risk by tumor synchronicity). Th us, we pooled data from the two cohorts in subsequent analyses.
Smoking habit and CRC risk by tumor synchronicity status
We tested our primary hypothesis, that there was a diff erential association of smoking with CRC incidence according to tumor synchronicity, in the combined cohort (with the adjusted α -level of 0.01). Th e association between smoking status (never, former, and current) and CRC incidence diff ered signifi cantly according to tumor synchronicity ( P heterogeneity <0.001; and solitary CRCs, but this association was signifi cantly stronger for synchronous CRCs ( P heterogeneity =0.006; Table 2 ). For example, compared with never smokers, those who smoked ≥40 pack-years had a multivariable HR for synchronous CRCs of 4.01 (95% CI, 1.67-9.65; P trend =0.001) compared to the corresponding multivariable HR of 1.20 (95% CI, 1.05-1.37; P trend =0.007) for solitary cancers.
Th ese longitudinal measures account for the smoking exposures most proximate to the time of diagnosis. However, given the time that may be required for CRC to develop, we also examined the association of early-life smoking exposures with incidence of CRC. Th e association of pack-years smoked before age 30 or age of initiation of smoking with CRC risk did not signifi cantly differ by tumor synchronicity status ( Table 2 ). However, smoking status as assessed at baseline (1980 for NHS and 1986 for HPFS), showed similar, yet slightly attenuated, associations as updated status. Compared with never smokers, current smokers at baseline had multivariable HRs of 1.11 (95% CI, 0.86-1.45; P trend =0.11) for solitary CRC and 4.31 (95% CI, 1.13-16.45; P trend =0.03; P heterogeneity = 0.05) for synchronous CRC.
Smoking cessation and colorectal cancer synchronicity
We further examined whether the risks associated with smoking were diminished aft er smoking cessation ( Table 3 ). Duration of smoking cessation (compared to current smoking) appeared to be signifi cantly associated with a lower risk of synchronous CRCs but not with the risk of solitary CRC ( P heterogeneity =0.001). Relative to current smokers, the multivariable HRs for synchronous CRCs were 0.53 (95% CI, 0.18-1.58) aft er smoking cessation of 1-9 years and 0.42 (95% CI, 0.19-0.95) aft er cessation ≥10 years ( P trend =0.001). As expected, the strongest inverse association was observed among never smokers (multivariable HR=0.19; 95% CI, 0.07-0.48).
Smoking status and colorectal cancer synchronicity stratifi ed by tumor molecular subtypes
Our previous studies have each independently associated synchronous CRCs and, separately, cigarette smoking with specifi c tumor molecular features that have been implicated in the serrated pathway of neoplasia, including CIMP-high, MSI-high, and BRAF mutation irrespective of tumor synchronicity ( 1, 27 ) . In the current analysis, we confi rmed that synchronous CRCs commonly exhibit these molecular alterations, with 47% (16/34) of synchronous cancers positive for at least one of these markers compared with 27% (321/1,207) of solitary CRC ( P =0.01; Table 4 ). Next, we attempted to examine the association of smoking with the risk of CRC according to synchronicity in context of their molecular subtypes. Th e total number of synchronous CRC cases was too 
DISCUSSION
In this prospective study of cigarette smoking and incidence of CRC according to tumor synchronicity, we showed that, compared with never smokers, a history of smoking and increasing number of pack-years smoked were associated with an increased risk of synchronous CRCs, which was signifi cantly stronger than that of solitary CRC. In contrast, smoking cessation compared with current smoking was specifi cally associated with a reduction in risk for synchronous CRCs. Moreover, given these associations and the absence of substantial heterogeneity according to early life-exposures, it appears that smoking habit more proximate to the time of diagnosis may be strongly associated with the development of synchronous neoplasms. Nonetheless, our data supports that smoking is a moderate risk factor for CRC overall.
small to be further stratifi ed by any or all of these molecular markers. However, we had suffi cient power to model the association of smoking with CRC according to subtypes defi ned as solitary cancers positive for CIMP-high, MSI-high, or BRAF mutation, and solitary cancers negative for these markers, or synchronous cancer ( Table 5 ). Current smoking, compared with never smoking, was associated with a multivariable HR of 1.07 (95% CI, 0.84-1.36) for solitary CRC that was BRAF wild-type, MSI-low or microsatellite stable, and CIMP-low or negative; 1.47 (95% CI, 1.02-2.12) for solitary CRC positive for any of BRAF mutation, MSI-high, and CIMP-high; and 5.35 (95% CI, 2.11-13.5) for synchronous CRC. Th us, the association of smoking with synchronous CRC appeared signifi cantly more pronounced compared to the association with solitary CRC positive for at least one of these serrated pathway-related markers ( P heterogeneity =0.002). ), family history of CRC in any fi rst-degree relative, regular use of aspirin, physical activity level (quintiles of mean MET score per week), red meat intake (quintiles of servings/day), total calorie intake (quintiles), alcohol consumption (0 or quartile of g/day), folate intake (quintiles of μ g/day), calcium intake (quintiles of mg/day) and current multivitamin intake. c Based on the linear trend test by using the ordinal or median continuous value for each of the categories as shown.
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Furthermore, as in our prior studies ( 1 ), we have demonstrated that synchronous CRCs more frequently possess molecular features characteristic of the serrated neoplasia pathway ( BRAF mutant, MSI-high, or CIMP-high). Our results appear consistent with a previous study demonstrating that synchronous advanced neoplasms may be more likely to arise from multiple sessile serrated adenomas ( 34 ) . Th e association of smoking with sessile serrated adenomas and the challenges of endoscopically detecting and removing these lesions, especially within the proximal colon, have been well documented (35) (36) (37) (38) (39) (40) (41) (42) (43) . Th us, both of these factors could signifi cantly contribute to the formation of multiple primary cancers and may explain the observed association between smoking and synchronous CRCs. Although we were unable to perform analyses further stratifi ed by anatomical subsite due to limited statistical power, we were able to stratify solitary CRC cases according to their molecular subtype to examine the possible mediation by these pathways. Although smoking was associated with a signifi cantly increased risk for solitary CRCs that are BRAF mutant, MSI-high, or CIMP-high, the risk of synchronous CRCs regardless of molecular subtype was signifi cantly more pronounced. Combined, our observations suggest that these molecular pathways may partially, but not completely, mediate the link between smoking and the formation of multiple primary tumors. Th is incomplete mediation suggests that additional studies focused on identifying additional markers of synchronous CRC risk are warranted; especially those that may infl uence serrated carcinogenesis. However, the link between smoking and traditional dysplastic adenoma incidence established by other studies suggests that these lesions may also contribute to multifocal tumor development ( 42,44,45 ) . a Multivariable tests for heterogeneity shows signifi cance ( P <0.01) of differential smoking effects on CRC risk by tumor synchronicity. The threshold for statistical significance ( α =0.01) was adjusted using conservative Bonferroni correction. b Models were stratifi ed by sex, age and time of questionnaire return. Multivariable models were adjusted for BMI (<25 vs. 25-30 vs. ≥30 kg/m2), family history of CRC in any fi rst-degree relative, regular use of aspirin, physical activity level (quintiles of mean metabolic equivalent (MET) task score per week), red meat intake (quintiles of servings/day), total calorie intake (quintiles), alcohol consumption (0 or quartile of g/day), folate intake (quintiles of μ g/day), calcium intake (quintiles of mg/day), current multivitamin intake and postmenopausal hormone use (NHS only). c Based on the linear trend test by using the ordinal categories among current and former smokers by additionally adjusting for never vs. ever smoking status. 
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Smoking and Synchronous Colorectal Cancers these potential factors. No signifi cant interaction was observed for smoking and sex on the incidence of CRC overall or by tumor synchronicity. Taken together, our data suggest that smoking in addition to other factors, signifi cantly contributes to a fi eld eff ect that encourages the formation of synchronous CRCs in part due to the presence of epigenetic dysregulation and the formation of multiple serrated neoplasms ( Figure 1 ). Th ere are several key strengths in our study. Our prospective design minimizes recall bias on smoking data and other relevant Th erefore, examination of the genetic markers associated with traditional carcinogenesis (e.g., APC or KRAS mutations) may also provide valuable insight ( 46 ) .
In addition, previous studies have linked other demographic and lifestyle factors with synchronous CRC incidence including age, family history and male sex ( 47, 48 ) . Our study, to our knowledge, is the fi rst to link smoking directly to synchronous CRC incidence. Th e current analyses were stratifi ed for age and sex and adjusted for family history to minimize confounding by ), family history of CRC in any fi rst-degree relative, regular use of aspirin, physical activity level (quintiles of mean MET score per week), red meat intake (quintiles of servings/day), total calorie intake (quintiles), alcohol consumption (0 or quartile of g/day), folate intake (quintiles of μ g/day), calcium intake (quintiles of mg/day), and current multivitamin intake. Solitary CRC cases with unknown molecular status were also included in the model as a separate outcome (data not shown). c Based on the linear trend test by using the ordinal values for each of the categories shown. CRC risk factor data. Questionnaire data were updated every 2 years allowing for the estimation of duration of smoking exposures and cessation as well as the ability to carefully control for potential confounding variables. Furthermore, our tumor data, carefully annotated for clinicopathological and molecular features, enabled us to use an integrative molecular pathologic epidemiology approach ( 32, 49 ) to test heterogeneity between diff erent outcomes (synchronous vs. solitary). Our study has limitations. First, despite our large population, synchronous cancers are relatively rare events, comprising <3% of all CRC cases. As such, we had a limited number of synchronous CRC cases for molecular analysis, which limited our ability to conduct more detailed mediation analyses. Although the association between smoking and synchronous cancer appears relatively strong (~5-fold increased relative risk), other factors are likely involved in the pathogenesis of synchronous CRC. Other risk factors for CRC (e.g., alcohol, body mass index, physical activity, and germ-line genetics) that are present throughout the life-course have not yet been associated with the presence of synchronous CRC. Th is may be explained by a distinct set of carcinogenic mechanisms associated with cigarette smoking that preferentially leads to a "fi eld carcinogenesis" eff ect defi ned by aberrant promoter methylation that leads to MSI and somatic BRAF mutations that favor serrated carcinogenesis. Nonetheless, further studies examining other CRC risk factors with tumor multiplicity (e.g., family history, age, and gender) ( 48 ) are warranted. Second, we were unable to obtain tumor tissue from all CRC cases. However, baseline features of participants without available tissue did not diff er from those with tissue ( 27 ) . Last, our cohorts represent a selected population of largely Caucasian health professionals and our fi ndings require validation in additional populations.
In summary, this prospective study suggests that smoking is associated with the risk of synchronous CRCs; this association is significantly stronger than that with the risk of solitary CRC. Furthermore, our results suggest that, compared with current smoking, smoking cessation is associated with a reduced risk of synchronous CRCs, implying that the field effect associated with smoking may be paused or reversed in the absence of exposure. Our results provide insight into the mechanisms of colorectal carcinogenesis and add further scientific support for the field effect theory of carcinogenesis. Moreover, these findings also highlight the importance of smoking cessation and abstinence as a component of CRC prevention strategies.
